ABSI
ABSI
NASDAQ · Biotechnology

Absci Corp

$2.85
-0.16 (-5.32%)
As of Mar 25, 3:01 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 13 87%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target +726.3% upside
Low Target $16.79
Average Target $23.55
High Target $35.63
Current Price $2.85
Current
$2.85
Target
$23.55
$16.79 $23.55 avg $35.63
Scenario Analysis
Bear Case
$16.79
489.1%
Low target
Base Case
$23.55
+726.3%
Avg target
Bull Case
$35.63
+1,150.2%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$5.23
-45.5% from high
52-Week Low
$2.01
+41.8% from low
Target vs 52W High
$23.55
+350.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%